| Tretinoin | Approved Investigational Nutraceutical | GLIS3 | 169792 |
downregulated | Tretinoin results in decreased expression of GLIS3 mRNA | 9p24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | GLOD4 | 51031 |
downregulated | Tretinoin results in decreased expression of GLOD4 mRNA | 17p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GLRB | 2743 |
upregulated | Tretinoin results in increased expression of GLRB mRNA | 4q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GLRX | 2745 |
upregulated | Tretinoin results in increased expression of GLRX mRNA | 5q15 | |
| Tretinoin | Approved Investigational Nutraceutical | GLS | 2744 |
upregulated | Tretinoin results in increased expression of GLS mRNA | 2q32.2 | |
| Tretinoin | Approved Investigational Nutraceutical | GLT1D1 | 144423 |
downregulated | Tretinoin results in decreased expression of GLT1D1 mRNA | 12q24.33 | |
| Tretinoin | Approved Investigational Nutraceutical | GLT8D2 | 83468 |
upregulated | Tretinoin results in increased expression of GLT8D2 mRNA | 12q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GLUD2 | 2747 |
downregulated | Tretinoin results in decreased expression of GLUD2 mRNA | Xq24 | |
| Tretinoin | Approved Investigational Nutraceutical | GLUL | 2752 |
upregulated | Tretinoin metabolite results in increased expression of GLUL mRNA | 1q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GLUL | 2752 |
downregulated | Tretinoin results in decreased expression of GLUL mRNA | 1q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GLUL | 2752 |
upregulated | Tretinoin results in increased expression of GLUL mRNA | 1q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GLYATL2 | 219970 |
upregulated | Tretinoin results in increased expression of GLYATL2 mRNA | 11q12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GM2A | 2760 |
upregulated | Tretinoin results in increased expression of GM2A mRNA | 5q33.1 | |
| Tretinoin | Approved Investigational Nutraceutical | GMEB1 | 10691 |
upregulated | Tretinoin results in increased expression of GMEB1 mRNA | 1p35.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GMPPA | 29926 |
downregulated | Tretinoin results in decreased expression of GMPPA mRNA | 2q35 | |
| Tretinoin | Approved Investigational Nutraceutical | GNAQ | 2776 |
downregulated | Tretinoin results in decreased expression of GNAQ mRNA | 9q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | GNAS | 2778 |
downregulated | Tretinoin results in decreased expression of GNAS mRNA | 20q13.32 | |
| Tretinoin | Approved Investigational Nutraceutical | GNAT1 | 2779 |
upregulated | Tretinoin results in increased expression of GNAT1 mRNA | 3p21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | GNAZ | 2781 |
downregulated | Tretinoin results in decreased expression of GNAZ mRNA | 22q11.22-q11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | GNB4 | 59345 |
downregulated | Tretinoin results in decreased expression of GNB4 mRNA | 3q26.33 | |
| Tretinoin | Approved Investigational Nutraceutical | GNE | 10020 |
upregulated | Tretinoin results in increased expression of GNE mRNA | 9p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GNG11 | 2791 |
downregulated | Tretinoin results in decreased expression of GNG11 mRNA | 7q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GNG11 | 2791 |
upregulated | Tretinoin results in increased expression of GNG11 mRNA | 7q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GNG4 | 2786 |
downregulated | Tretinoin results in decreased expression of GNG4 mRNA | 1q42.3 | |
| Tretinoin | Approved Investigational Nutraceutical | GNGT1 | 2792 |
upregulated | Tretinoin results in increased expression of GNGT1 mRNA | 7q21.3 | |